Characterization of clinically significant isolates of Staphylococcus epidermidis from patients with endocarditis
about
Effects of subinhibitory concentrations of vancomycin or cefamandole on biofilm production by coagulase-negative staphylococci.Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm.Prevalence of peritonitis-associated coagulase-negative staphylococci on the skin of continuous ambulatory peritoneal dialysis patients.Characterization of clinically significant isolates of Staphylococcus epidermidis from patients with cerebrospinal fluid shunt infections.Serological typing of coagulase-negative staphylococci using monoclonal antibodies.Species distribution of coagulase-negative staphylococcal isolates at a community hospital and implications for selection of staphylococcal identification proceduresCharacterization of unrelated strains of Staphylococcus schleiferi by using ribosomal DNA fingerprinting, DNA restriction patterns, and plasmid profilesRestriction endonuclease analysis of Staphylococcus epidermidis DNA may be a useful epidemiological marker.Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites.Molecular epidemiology of Staphylococcus haemolyticus strains isolated in an Albanian hospitalSlime production and expression of the slime-associated antigen by staphylococcal clinical isolates.Comparative study of hemolytic substances produced by coagulase-negative Staphylococcus strains.Association of coagulase-negative staphylococcal slime production and adherence with the development and outcome of adult septicemias.Evaluation of restriction endonuclease fingerprinting of chromosomal DNA and plasmid profile analysis for characterization of multiresistant coagulase-negative staphylococci in bacteremic neonates.Application of gas-liquid chromatographic analysis of cellular fatty acids for species identification and typing of coagulase-negative staphylococci.
P2860
Q35249874-396909D9-5E14-400D-8009-18CE57FA4F50Q35903859-2283C471-4E98-402C-9D5C-03C7A4435FEBQ36473200-BA012217-273D-4D93-AF36-3CE240BAC5FBQ36505185-682A3B72-A94E-4895-83BE-DBBDA306CD33Q36505625-48D36E48-B296-45D9-943C-5FB3BB3B378FQ37068495-46393D68-4EF2-4313-B224-268540680A5FQ37083406-61680C0D-1D6B-4024-99BA-A8782DA8FAF1Q37153749-65DF8958-EF5F-4C94-9782-DDC4041A11C4Q37189232-2A85CC77-58F7-42CF-B36A-0862A10AF24DQ37240122-F0ECD002-89C3-4381-B2BD-F8F24053DBECQ39452292-A48CFBE0-C018-42F6-8CB0-58972378364EQ40154901-C6D0437C-DD51-47A2-AB13-2CC403C65E1DQ40203401-EB22B2AC-5396-4E04-B1E5-C7DFBE35DFB9Q40210279-C3C61CDB-2EF1-4B7A-B7CC-0A106EC1D03BQ40211138-3738EF0C-B3E1-4188-B9CD-58E03754C972
P2860
Characterization of clinically significant isolates of Staphylococcus epidermidis from patients with endocarditis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1988
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of clinically ...... rom patients with endocarditis
@en
Characterization of clinically ...... om patients with endocarditis.
@nl
type
label
Characterization of clinically ...... rom patients with endocarditis
@en
Characterization of clinically ...... om patients with endocarditis.
@nl
prefLabel
Characterization of clinically ...... rom patients with endocarditis
@en
Characterization of clinically ...... om patients with endocarditis.
@nl
P2093
P2860
P1476
Characterization of clinically ...... rom patients with endocarditis
@en
P2093
Fleurette J
P2860
P304
P407
P577
1988-04-01T00:00:00Z